Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023

Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation

Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation

Fresenius Medical Care AG & Co. KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board

Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022